Your browser doesn't support javascript.
loading
Rho kinase inhibitor for primary open-angle glaucoma and ocular hypertension.
Clement Freiberg, Josefine; von Spreckelsen, Alexander; Kolko, Miriam; Azuara-Blanco, Augusto; Virgili, Gianni.
Afiliação
  • Clement Freiberg J; Department of Drug Design and Pharmacology, University of Copenhagen, Copenhagen, Denmark.
  • von Spreckelsen A; Department of Drug Design and Pharmacology, University of Copenhagen, Copenhagen, Denmark.
  • Kolko M; Department of Ophthalmology and Department of Drug Design and Pharmacology, Copenhagen University Hospital, University of Copenhagen, Copenhagen, Denmark.
  • Azuara-Blanco A; Centre for Public Health, Queen's University Belfast, Belfast, UK.
  • Virgili G; Department of Neurosciences, Psychology, Drug Research and Child Health (NEUROFARBA), University of Florence, Florence, Italy.
Cochrane Database Syst Rev ; 6: CD013817, 2022 06 10.
Article em En | MEDLINE | ID: mdl-35686679
Assuntos
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Glaucoma de Ângulo Aberto / Hipertensão Ocular / Quinases Associadas a rho Idioma: En Ano de publicação: 2022 Tipo de documento: Article País de afiliação: Dinamarca
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Glaucoma de Ângulo Aberto / Hipertensão Ocular / Quinases Associadas a rho Idioma: En Ano de publicação: 2022 Tipo de documento: Article País de afiliação: Dinamarca